Suchergebnisse - "Pfeffer, Marc A."

PubPharm (832)

1

Sacubitril/Valsartan-Related Hypotension in Patients with Heart Failure and Preserved or Mildly Reduced Ejection Fraction

enthalten in: Journal of the American College of Cardiology | 2024

von Foà, A. | Vaduganathan, M. | Claggett, B. | +12

2

Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI

enthalten in: Journal of the American College of Cardiology | 2024

von Mann, D. | Nicolas, J. | Claggett, B. | +17

3

Long-term cardiovascular events, graft failure, and mortality in kidney transplant recipients

enthalten in: European journal of internal medicine | 2024

von Andersson, C. | Hansen, D. | Sørensen, S. | +6

4

High-sensitivity C-reactive protein in heart failure with preserved ejection fraction : Findings from TOPCAT

enthalten in: International journal of cardiology | 2024

von Ferreira, J. | Claggett, B. | Liu, J. | +10

5

New Clinical Challenges for Health Providers in the Prescription of Statins in the Elderly

enthalten in: The American journal of medicine | 2024

von Hennekens, C. | Desai, A. | Bandi, R. | +3

6

Pulmonary Congestion and Left Ventricular Dysfunction After Myocardial Infarction : Insights From the PARADISE-MI Trial

enthalten in: Circulation | 2024

von Petrie, M. | Rouleau, J. | Claggett, B. | +16

7

Heart failure with preserved ejection fraction, red cell distribution width, and sacubitril/valsartan

enthalten in: ESC heart failure | 2024

von Butt, J. | McDowell, K. | Kondo, T. | +12

8

Sacubitril/valsartan compared to ramipril in high-risk post-myocardial infarction patients stratified according to use of mineralocorticoid receptor antagonists : Insight from the PARADISE MI trial

enthalten in: European journal of heart failure | 2024

von Schou, M. | Claggett, B. | Miao, Z. | +20

9

Heart failure with preserved ejection fraction, red cell distribution width, and sacubitril/valsartan

enthalten in: ESC Heart Failure | 2024

von Butt, J. | McDowell, K. | Kondo, T. | +12

10

Sacubitril/valsartan compared to ramipril in high‐risk post‐myocardial infarction patients stratified according to use of mineralocorticoid receptor antagonists : Insight from the PARADISE MI trial

enthalten in: European Journal of Heart Failure | 2024

von Schou, M. | Claggett, B. | Miao, Z. | +20

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[84]